Research suggests that therapy involving a type of medication known as GLP-1, which is found in certain drugs, may help reduce heavy drinking, particularly among individuals with obesity. The potential treatment has shown promise in studies, with some findings indicating that it may work by targeting reward pathways in the brain. The effectiveness of GLP-1 therapy for treating alcohol use disorder is being explored in various studies, with some investigations focusing on specific medications and patient populations.